Gustav Schonfeld Selected Research

Hypobetalipoproteinemias (Hypobetalipoproteinemia)

6/2011	Plasma non-cholesterol sterols in primary hypobetalipoproteinemia.
4/2011	Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
7/2010	Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
1/2008	Fatty liver and insulin resistance: not always linked.
6/2006	A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation.
7/2005	Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
1/2005	Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL.
5/2004	Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
1/2004	Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.
3/2003	Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gustav Schonfeld Research Topics

Disease

13	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 06/2011 - 03/2002
6	Fatty Liver 06/2006 - 03/2002
3	Insulin Resistance 07/2010 - 05/2004
3	Obesity 01/2008 - 03/2003
2	Atherosclerosis 07/2010 - 04/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2008 - 01/2008
1	Non-alcoholic Fatty Liver Disease 07/2010
1	Type 2 Diabetes Mellitus (MODY) 10/2008
1	Dyslipidemias (Dyslipidemia) 10/2008
1	Glucose Intolerance 01/2008
1	Coronary Disease (Coronary Heart Disease) 12/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2007
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2002

Drug/Important Bio-Agent (IBA)

15	Apolipoproteins B (ApoB)IBA 04/2011 - 03/2002
12	ApolipoproteinsIBA 04/2011 - 03/2002
8	Triglycerides (Triacylglycerol)IBA 07/2010 - 03/2002
3	Lipoproteins (Lipoprotein)IBA 04/2011 - 04/2003
3	Insulin (Novolin)FDA Link 07/2010 - 03/2003
3	LipidsIBA 10/2008 - 06/2006
3	oxidized low density lipoproteinIBA 10/2008 - 03/2002
3	LDL CholesterolIBA 12/2007 - 03/2002
2	CholesterolIBA 06/2011 - 04/2003
2	Glucose (Dextrose)FDA LinkGeneric 07/2010 - 03/2003
2	Apolipoprotein B-100 (Apo B 100)IBA 04/2003 - 08/2002
1	SterolsIBA 06/2011
1	Phytosterols (Plant Sterols)IBA 07/2010
1	HDL LipoproteinsIBA 10/2008
1	HDL CholesterolIBA 10/2008
1	VLDL LipoproteinsIBA 06/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2006
1	Apolipoprotein B-48IBA 04/2003

Therapy/Procedure

1	Therapeutics 10/2008